1321 Upland Dr. PMB 20205, Houston, Texas, 77043, US +1 210-775-2636 (USA) sales@refinedreportsdata.com
Dendritic Cell Vaccine Market, Global Outlook and Forecast 2022-2028





Dendritic Cell Vaccine Market, Global Outlook and Forecast 2022-2028   

Report to be delivered immediately.

Dendritic cells (DCs) have several characteristics that make them an ideal vehicle for tumor vaccines, and with the first US FDA-approved DC-based vaccine in use for the treatment of prostate cancer, this technology has become a promising new therapeutic option.
This report contains market size and forecasts of Dendritic Cell Vaccine in global, including the following market information:
Global Dendritic Cell Vaccine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dendritic Cell Vaccine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Dendritic Cell Vaccine companies in 2021 (%)
The global Dendritic Cell Vaccine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Non-Targeted Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dendritic Cell Vaccine include 3M, Activarti, Argos Therapeutics, Batavia Bioservices, Bellicum Pharmaceuticals, Creagene, DanDrit Biotech, DCPrime and Sanpower Corporation (Dendreon Corporation), etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dendritic Cell Vaccine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dendritic Cell Vaccine Market, By Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dendritic Cell Vaccine Market Segment Percentages, By Type, 2021 (%)
Non-Targeted
Target
Global Dendritic Cell Vaccine Market, By Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dendritic Cell Vaccine Market Segment Percentages, By Application, 2021 (%)
Covid-19
Cancer
Others
Global Dendritic Cell Vaccine Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Dendritic Cell Vaccine Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dendritic Cell Vaccine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dendritic Cell Vaccine revenues share in global market, 2021 (%)
Key companies Dendritic Cell Vaccine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Dendritic Cell Vaccine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
3M
Activarti
Argos Therapeutics
Batavia Bioservices
Bellicum Pharmaceuticals
Creagene
DanDrit Biotech
DCPrime
Sanpower Corporation (Dendreon Corporation)
Elios Therapeutics
ImmunoCellular Therapeutics
Immunicum
Kiromic
Medigene
Merck & Co.
Northwest Biotherapeutics
Glaxo Smith Kline
Tella Incorporation
Vaxil BioTherapeutics

Free Sample Reports

1 Introduction to Research & Analysis Reports
1.1 Dendritic Cell Vaccine Market Definition
1.2 Market Segments
1.2.1 Market By Type
1.2.2 Market By Application
1.3 Global Dendritic Cell Vaccine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dendritic Cell Vaccine Overall Market Size
2.1 Global Dendritic Cell Vaccine Market Size: 2021 VS 2028
2.2 Global Dendritic Cell Vaccine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Dendritic Cell Vaccine Sales: 2017-2028
3 Company Landscape
3.1 Top Dendritic Cell Vaccine Players in Global Market
3.2 Top Global Dendritic Cell Vaccine Companies Ranked by Revenue
3.3 Global Dendritic Cell Vaccine Revenue by Companies
3.4 Global Dendritic Cell Vaccine Sales by Companies
3.5 Global Dendritic Cell Vaccine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Dendritic Cell Vaccine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Dendritic Cell Vaccine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dendritic Cell Vaccine Players in Global Market
3.8.1 List of Global Tier 1 Dendritic Cell Vaccine Companies
3.8.2 List of Global Tier 2 and Tier 3 Dendritic Cell Vaccine Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Dendritic Cell Vaccine Market Size Markets, 2021 & 2028
4.1.2 Non-Targeted
4.1.3 Target
4.2 By Type - Global Dendritic Cell Vaccine Revenue & Forecasts
4.2.1 By Type - Global Dendritic Cell Vaccine Revenue, 2017-2022
4.2.2 By Type - Global Dendritic Cell Vaccine Revenue, 2023-2028
4.2.3 By Type - Global Dendritic Cell Vaccine Revenue Market Share, 2017-2028
4.3 By Type - Global Dendritic Cell Vaccine Sales & Forecasts
4.3.1 By Type - Global Dendritic Cell Vaccine Sales, 2017-2022
4.3.2 By Type - Global Dendritic Cell Vaccine Sales, 2023-2028
4.3.3 By Type - Global Dendritic Cell Vaccine Sales Market Share, 2017-2028
4.4 By Type - Global Dendritic Cell Vaccine Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global Dendritic Cell Vaccine Market Size, 2021 & 2028
5.1.2 Covid-19
5.1.3 Cancer
5.1.4 Others
5.2 By Application - Global Dendritic Cell Vaccine Revenue & Forecasts
5.2.1 By Application - Global Dendritic Cell Vaccine Revenue, 2017-2022
5.2.2 By Application - Global Dendritic Cell Vaccine Revenue, 2023-2028
5.2.3 By Application - Global Dendritic Cell Vaccine Revenue Market Share, 2017-2028
5.3 By Application - Global Dendritic Cell Vaccine Sales & Forecasts
5.3.1 By Application - Global Dendritic Cell Vaccine Sales, 2017-2022
5.3.2 By Application - Global Dendritic Cell Vaccine Sales, 2023-2028
5.3.3 By Application - Global Dendritic Cell Vaccine Sales Market Share, 2017-2028
5.4 By Application - Global Dendritic Cell Vaccine Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global Dendritic Cell Vaccine Market Size, 2021 & 2028
6.2 By Region - Global Dendritic Cell Vaccine Revenue & Forecasts
6.2.1 By Region - Global Dendritic Cell Vaccine Revenue, 2017-2022
6.2.2 By Region - Global Dendritic Cell Vaccine Revenue, 2023-2028
6.2.3 By Region - Global Dendritic Cell Vaccine Revenue Market Share, 2017-2028
6.3 By Region - Global Dendritic Cell Vaccine Sales & Forecasts
6.3.1 By Region - Global Dendritic Cell Vaccine Sales, 2017-2022
6.3.2 By Region - Global Dendritic Cell Vaccine Sales, 2023-2028
6.3.3 By Region - Global Dendritic Cell Vaccine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Dendritic Cell Vaccine Revenue, 2017-2028
6.4.2 By Country - North America Dendritic Cell Vaccine Sales, 2017-2028
6.4.3 US Dendritic Cell Vaccine Market Size, 2017-2028
6.4.4 Canada Dendritic Cell Vaccine Market Size, 2017-2028
6.4.5 Mexico Dendritic Cell Vaccine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Dendritic Cell Vaccine Revenue, 2017-2028
6.5.2 By Country - Europe Dendritic Cell Vaccine Sales, 2017-2028
6.5.3 Germany Dendritic Cell Vaccine Market Size, 2017-2028
6.5.4 France Dendritic Cell Vaccine Market Size, 2017-2028
6.5.5 U.K. Dendritic Cell Vaccine Market Size, 2017-2028
6.5.6 Italy Dendritic Cell Vaccine Market Size, 2017-2028
6.5.7 Russia Dendritic Cell Vaccine Market Size, 2017-2028
6.5.8 Nordic Countries Dendritic Cell Vaccine Market Size, 2017-2028
6.5.9 Benelux Dendritic Cell Vaccine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Dendritic Cell Vaccine Revenue, 2017-2028
6.6.2 By Region - Asia Dendritic Cell Vaccine Sales, 2017-2028
6.6.3 China Dendritic Cell Vaccine Market Size, 2017-2028
6.6.4 Japan Dendritic Cell Vaccine Market Size, 2017-2028
6.6.5 South Korea Dendritic Cell Vaccine Market Size, 2017-2028
6.6.6 Southeast Asia Dendritic Cell Vaccine Market Size, 2017-2028
6.6.7 India Dendritic Cell Vaccine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Dendritic Cell Vaccine Revenue, 2017-2028
6.7.2 By Country - South America Dendritic Cell Vaccine Sales, 2017-2028
6.7.3 Brazil Dendritic Cell Vaccine Market Size, 2017-2028
6.7.4 Argentina Dendritic Cell Vaccine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Dendritic Cell Vaccine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Dendritic Cell Vaccine Sales, 2017-2028
6.8.3 Turkey Dendritic Cell Vaccine Market Size, 2017-2028
6.8.4 Israel Dendritic Cell Vaccine Market Size, 2017-2028
6.8.5 Saudi Arabia Dendritic Cell Vaccine Market Size, 2017-2028
6.8.6 UAE Dendritic Cell Vaccine Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 3M
7.1.1 3M Corporate Summary
7.1.2 3M Business Overview
7.1.3 3M Dendritic Cell Vaccine Major Product Offerings
7.1.4 3M Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.1.5 3M Key News
7.2 Activarti
7.2.1 Activarti Corporate Summary
7.2.2 Activarti Business Overview
7.2.3 Activarti Dendritic Cell Vaccine Major Product Offerings
7.2.4 Activarti Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.2.5 Activarti Key News
7.3 Argos Therapeutics
7.3.1 Argos Therapeutics Corporate Summary
7.3.2 Argos Therapeutics Business Overview
7.3.3 Argos Therapeutics Dendritic Cell Vaccine Major Product Offerings
7.3.4 Argos Therapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.3.5 Argos Therapeutics Key News
7.4 Batavia Bioservices
7.4.1 Batavia Bioservices Corporate Summary
7.4.2 Batavia Bioservices Business Overview
7.4.3 Batavia Bioservices Dendritic Cell Vaccine Major Product Offerings
7.4.4 Batavia Bioservices Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.4.5 Batavia Bioservices Key News
7.5 Bellicum Pharmaceuticals
7.5.1 Bellicum Pharmaceuticals Corporate Summary
7.5.2 Bellicum Pharmaceuticals Business Overview
7.5.3 Bellicum Pharmaceuticals Dendritic Cell Vaccine Major Product Offerings
7.5.4 Bellicum Pharmaceuticals Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.5.5 Bellicum Pharmaceuticals Key News
7.6 Creagene
7.6.1 Creagene Corporate Summary
7.6.2 Creagene Business Overview
7.6.3 Creagene Dendritic Cell Vaccine Major Product Offerings
7.6.4 Creagene Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.6.5 Creagene Key News
7.7 DanDrit Biotech
7.7.1 DanDrit Biotech Corporate Summary
7.7.2 DanDrit Biotech Business Overview
7.7.3 DanDrit Biotech Dendritic Cell Vaccine Major Product Offerings
7.7.4 DanDrit Biotech Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.7.5 DanDrit Biotech Key News
7.8 DCPrime
7.8.1 DCPrime Corporate Summary
7.8.2 DCPrime Business Overview
7.8.3 DCPrime Dendritic Cell Vaccine Major Product Offerings
7.8.4 DCPrime Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.8.5 DCPrime Key News
7.9 Sanpower Corporation (Dendreon Corporation)
7.9.1 Sanpower Corporation (Dendreon Corporation) Corporate Summary
7.9.2 Sanpower Corporation (Dendreon Corporation) Business Overview
7.9.3 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Major Product Offerings
7.9.4 Sanpower Corporation (Dendreon Corporation) Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.9.5 Sanpower Corporation (Dendreon Corporation) Key News
7.10 Elios Therapeutics
7.10.1 Elios Therapeutics Corporate Summary
7.10.2 Elios Therapeutics Business Overview
7.10.3 Elios Therapeutics Dendritic Cell Vaccine Major Product Offerings
7.10.4 Elios Therapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.10.5 Elios Therapeutics Key News
7.11 ImmunoCellular Therapeutics
7.11.1 ImmunoCellular Therapeutics Corporate Summary
7.11.2 ImmunoCellular Therapeutics Dendritic Cell Vaccine Business Overview
7.11.3 ImmunoCellular Therapeutics Dendritic Cell Vaccine Major Product Offerings
7.11.4 ImmunoCellular Therapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.11.5 ImmunoCellular Therapeutics Key News
7.12 Immunicum
7.12.1 Immunicum Corporate Summary
7.12.2 Immunicum Dendritic Cell Vaccine Business Overview
7.12.3 Immunicum Dendritic Cell Vaccine Major Product Offerings
7.12.4 Immunicum Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.12.5 Immunicum Key News
7.13 Kiromic
7.13.1 Kiromic Corporate Summary
7.13.2 Kiromic Dendritic Cell Vaccine Business Overview
7.13.3 Kiromic Dendritic Cell Vaccine Major Product Offerings
7.13.4 Kiromic Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.13.5 Kiromic Key News
7.14 Medigene
7.14.1 Medigene Corporate Summary
7.14.2 Medigene Business Overview
7.14.3 Medigene Dendritic Cell Vaccine Major Product Offerings
7.14.4 Medigene Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.14.5 Medigene Key News
7.15 Merck & Co.
7.15.1 Merck & Co. Corporate Summary
7.15.2 Merck & Co. Business Overview
7.15.3 Merck & Co. Dendritic Cell Vaccine Major Product Offerings
7.15.4 Merck & Co. Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.15.5 Merck & Co. Key News
7.16 Northwest Biotherapeutics
7.16.1 Northwest Biotherapeutics Corporate Summary
7.16.2 Northwest Biotherapeutics Business Overview
7.16.3 Northwest Biotherapeutics Dendritic Cell Vaccine Major Product Offerings
7.16.4 Northwest Biotherapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.16.5 Northwest Biotherapeutics Key News
7.17 Glaxo Smith Kline
7.17.1 Glaxo Smith Kline Corporate Summary
7.17.2 Glaxo Smith Kline Business Overview
7.17.3 Glaxo Smith Kline Dendritic Cell Vaccine Major Product Offerings
7.17.4 Glaxo Smith Kline Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.17.5 Glaxo Smith Kline Key News
7.18 Tella Incorporation
7.18.1 Tella Incorporation Corporate Summary
7.18.2 Tella Incorporation Business Overview
7.18.3 Tella Incorporation Dendritic Cell Vaccine Major Product Offerings
7.18.4 Tella Incorporation Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.18.5 Tella Incorporation Key News
7.19 Vaxil BioTherapeutics
7.19.1 Vaxil BioTherapeutics Corporate Summary
7.19.2 Vaxil BioTherapeutics Business Overview
7.19.3 Vaxil BioTherapeutics Dendritic Cell Vaccine Major Product Offerings
7.19.4 Vaxil BioTherapeutics Dendritic Cell Vaccine Sales and Revenue in Global (2017-2022)
7.19.5 Vaxil BioTherapeutics Key News
8 Global Dendritic Cell Vaccine Production Capacity, Analysis
8.1 Global Dendritic Cell Vaccine Production Capacity, 2017-2028
8.2 Dendritic Cell Vaccine Production Capacity of Key Manufacturers in Global Market
8.3 Global Dendritic Cell Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dendritic Cell Vaccine Supply Chain Analysis
10.1 Dendritic Cell Vaccine Industry Value Chain
10.2 Dendritic Cell Vaccine Upstream Market
10.3 Dendritic Cell Vaccine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dendritic Cell Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer













Our Client




Q. What is the scope of the report?

This market study covers the global and regional market with an
in-depth analysis of the overall growth prospects in the market.
Furthermore, it sheds light on the comprehensive competitive landscape
of the global market. The report further offers a dashboard overview of
leading companies encompassing their successful marketing strategies,
market contribution, recent developments in both historic and present
contexts.


Q. What are the key segments in the market?

  • By product type
  • By End User/Applications
  • By Regions


Q. Which market dynamics affect the business?

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.



FAQ




Get In Touch

1321 Upland Dr. PMB 20205, Houston, Texas, 77043, US

sales@refinedreportsdata.com

+1 210-775-2636 (USA)

©2024 RefinedReportsData. All Rights Reserved.